Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03139266 · ClinicalTrials.gov registry record · NA

Project UPLIFT to Reduce Anxiety and Depression in CF Patients

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
85
Enrollment target

NCT03139266 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 85 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03139266, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target

Study Summary

People with CF have elevated rates of anxiety and depression when compared to the general population. Anxiety and depression can have a negative impact on adherence and disease self-management, leading to worse CF health outcomes such as respiratory symptoms, functional capacity, and health-related quality of life (HRQOL). Project UPLIFT is a group mental health intervention that can be delivered by telephone or Web, though for this study the intervention will be web based only. Project UPLIFT was originally developed as a depression treatment and prevention program for people with epilepsy and was shown to be effective in reducing depression and increasing knowledge and skills. Recently, Project UPLIFT was revised to help people with CF manage their depression and anxiety and shown to be apparently successful in a pilot study that included adolescents and adults with CF. The goals of this project are to determine the effectiveness of Project UPLIFT in reducing anxiety and depression in adolescents and adults with CF, as well as increasing their quality of life and other physical health-related disease outcomes.

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL UPLIFT

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2015-04-07
Est. Completion 2022-08-02
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT03139266

The ClinicalTrials.gov registry entry for NCT03139266 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.

NCT03139266 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03139266 about?

NCT03139266 is a clinical study titled "Project UPLIFT to Reduce Anxiety and Depression in CF Patients". People with CF have elevated rates of anxiety and depression when compared to the general population. Anxiety and depression can have a negative impact on adherence and disease self-management, leading to worse CF health outcomes such as respiratory symptoms, functional capacity, and health-related ...

What is the current status of trial NCT03139266?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2015-04-07. Estimated completion is 2022-08-02.

What interventions are being tested in trial NCT03139266?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), UPLIFT (BEHAVIORAL).

Who is sponsoring clinical trial NCT03139266?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.